BIOLITMAP: a web-based geolocated, temporal and thematic visualization of the evolution of bioinformatics publications.

MOTIVATION: The fast growth of bioinformatics adds a significant difficulty to assess the contribution, geographical and thematic distribution of the research publications. RESULTS: To help researchers, grant agencies and general public to assess the progress in bioinformatics, we have developed BIOLITMAP, a web-based geolocation system that allows an easy and sensible exploration of the publications by institution, year and topic. AVAILABILITY AND IMPLEMENTATION: BIOLITMAP is available at http://socialanalytics.bsc.es/biolitmap and the sources have been deposited at https://github.com/inab/BIOLITMAP. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

HumanMine: advanced data searching, analysis and cross-species comparison.

HumanMine (www.humanmine.org) is an integrated database of human genomics and proteomics data that provides a powerful interface to support sophisticated exploration and analysis of data compiled from experimental, computational and curated data sources. Built using the InterMine data integration platform, HumanMine includes genes, proteins, pathways, expression levels, Single nucleotide polymorphism (SNP), diseases and more, integrated into a single searchable database. HumanMine promotes integrative analysis, a powerful approach in modern biology that allows many sources of evidence to be analysed together. The data can be accessed through a user-friendly web interface as well as a powerful, scriptable web service Application programming interface (API) to allow programmatic access to data. The web interface includes a useful identifier resolution system, sophisticated query options and interactive results tables that enable powerful exploration of data, including data summaries, filtering, browsing and export. A set of graphical analysis tools provide a rich environment for data exploration including statistical enrichment of sets of genes or other biological entities. HumanMine can be used for integrative multistaged analysis that can lead to new insights and uncover previously unknown relationships. Database URL: https://www.humanmine.org.

Translating synthetic natural language to database queries with a polyglot deep learning framework.

The number of databases as well as their size and complexity is increasing. This creates a barrier to use especially for non-experts, who have to come to grips with the nature of the data, the way it has been represented in the database, and the specific query languages or user interfaces by which data are accessed. These difficulties worsen in research settings, where it is common to work with many different databases. One approach to improving this situation is to allow users to pose their queries in natural language. In this work we describe a machine learning framework, Polyglotter, that in a general way supports the mapping of natural language searches to database queries. Importantly, it does not require the creation of manually annotated data for training and therefore can be applied easily to multiple domains. The framework is polyglot in the sense that it supports multiple different database engines that are accessed with a variety of query languages, including SQL and Cypher. Furthermore Polyglotter supports multi-class queries. Good performance is achieved on both toy and real databases, as well as a human-annotated WikiSQL query set. Thus Polyglotter may help database maintainers make their resources more accessible.

Genome-wide investigation of gene-cancer associations for the prediction of novel therapeutic targets in oncology.

A major cause of failed drug discovery programs is suboptimal target selection, resulting in the development of drug candidates that are potent inhibitors, but ineffective at treating the disease. In the genomics era, the availability of large biomedical datasets with genome-wide readouts has the potential to transform target selection and validation. In this study we investigate how computational intelligence methods can be applied to predict novel therapeutic targets in oncology. We compared different machine learning classifiers applied to the task of drug target classification for nine different human cancer types. For each cancer type, a set of "known" target genes was obtained and equally-sized sets of "non-targets" were sampled multiple times from the human protein-coding genes. Models were trained on mutation, gene expression (TCGA), and gene essentiality (DepMap) data. In addition, we generated a numerical embedding of the interaction network of protein-coding genes using deep network representation learning and included the results in the modeling. We assessed feature importance using a random forests classifier and performed feature selection based on measuring permutation importance against a null distribution. Our best models achieved good generalization performance based on the AUROC metric. With the best model for each cancer type, we ran predictions on more than 15,000 protein-coding genes to identify potential novel targets. Our results indicate that this approach may be useful to inform early stages of the drug discovery pipeline.